Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

What symbol and exchange does Neuraxis shares trade?

Neuraxis trades on the AMEX stock market under the symbol NRXS.

What is Neuraxis stock price doing today?

As of November 12, 2026, NRXS stock price declined to $5.75 with 178,368 million shares trading.

What is Neuraxis's Beta?

NRXS has a beta of 0.65, meaning it tends to be less sensitive to market movements. NRXS has a correlation of 0.01 to the broad based SPY ETF.

How much is Neuraxis worth?

NRXS has a market cap of $81.61 million. This is considered a Micro Cap stock.

How much money does Neuraxis make?

Last quarter Neuraxis reported $2 million in Revenue and -$.52 earnings per share. This fell short of revenue expectation by $-72,000 and missed earnings estimates by -$.31.

What is the highest and lowest price Neuraxis traded in the last 3 year period?

In the last 3 years, NRXS traded as high as $9.33 and as low as $1.33.

What are the top ETFs holding Neuraxis?

The top ETF exchange traded funds that NRXS belongs to (by Net Assets): VTI, VXF, IWC, BUSM.

Is Neuraxis (NRXS) a good investment?

NRXS has outperformed the market in the last year with a return of +138.6%, while the SPY ETF gained +12.0%. However, in the most recent history, NRXS shares have underperformed the stock market with its stock returning -9.4% in the last 3 month period and -24.0% for the last 2 week period, while SPY has returned -1.5% and -2.0%, respectively.

What are the support and resistance levels for Neuraxis (NRXS)?

NRXS support price is $5.70 and resistance is $6.36 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRXS shares will trade within this expected range on the day.